Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Swedish Orphan Biovitrum Keeps Outlook 2026 Unchanged

April 28 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

SOBI Q1 ADJUSTED FREE CASH FLOW SEK 1,126 MILLION

SOBI Q1 REVENUE SEK 7,184 MILLION VERSUS. IBES ESTIMATE SEK 7,152 MILLION

SOBI Q1 EBIT SEK 1,868 MILLION VERSUS. IBES ESTIMATE SEK 1,793 MILLION

SOBI Q1 ADJUSTED EPS SEK 3.81

SWEDISH ORPHAN BIOVITRUM - OUTLOOK 2026  UNCHANGED

Source text: ID:nWkr90Ryd8

Further company coverage: SOBIV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Swedish Orphan Biovitrum AB (publ)

See all news